107 related articles for article (PubMed ID: 15386717)
1. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly.
Hanlon JT; Landerman LR; Artz MB; Gray SL; Fillenbaum GG; Schmader KE
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):781-7. PubMed ID: 15386717
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine use and cognitive function among community-dwelling elderly.
Hanlon JT; Horner RD; Schmader KE; Fillenbaum GG; Lewis IK; Wall WE; Landerman LR; Pieper CF; Blazer DG; Cohen HJ
Clin Pharmacol Ther; 1998 Dec; 64(6):684-92. PubMed ID: 9871433
[TBL] [Abstract][Full Text] [Related]
3. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
[TBL] [Abstract][Full Text] [Related]
4. The combined effect of visual impairment and cognitive impairment on disability in older people.
Whitson HE; Cousins SW; Burchett BM; Hybels CF; Pieper CF; Cohen HJ
J Am Geriatr Soc; 2007 Jun; 55(6):885-91. PubMed ID: 17537089
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic drug use and cognitive decline among older men and women.
Dealberto MJ; Mcavay GJ; Seeman T; Berkman L
Int J Geriatr Psychiatry; 1997 May; 12(5):567-74. PubMed ID: 9193967
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging.
Chodosh J; Kado DM; Seeman TE; Karlamangla AS
Am J Geriatr Psychiatry; 2007 May; 15(5):406-15. PubMed ID: 17353297
[TBL] [Abstract][Full Text] [Related]
7. Urinary incontinence in older community-dwelling women: the role of cognitive and physical function decline.
Huang AJ; Brown JS; Thom DH; Fink HA; Yaffe K;
Obstet Gynecol; 2007 Apr; 109(4):909-16. PubMed ID: 17400853
[TBL] [Abstract][Full Text] [Related]
8. Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort.
Purser JL; Fillenbaum GG; Pieper CF; Wallace RB
J Am Geriatr Soc; 2005 Nov; 53(11):1966-72. PubMed ID: 16274380
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly.
Saag KG; Rubenstein LM; Chrischilles EA; Wallace RB
J Rheumatol; 1995 Nov; 22(11):2142-7. PubMed ID: 8596158
[TBL] [Abstract][Full Text] [Related]
10. Plasma selenium over time and cognitive decline in the elderly.
Akbaraly TN; Hininger-Favier I; Carrière I; Arnaud J; Gourlet V; Roussel AM; Berr C
Epidemiology; 2007 Jan; 18(1):52-8. PubMed ID: 17130689
[TBL] [Abstract][Full Text] [Related]
11. Is antioxidant use protective of cognitive function in the community-dwelling elderly?
Gray SL; Hanlon JT; Landerman LR; Artz M; Schmader KE; Fillenbaum GG
Am J Geriatr Pharmacother; 2003 Sep; 1(1):3-10. PubMed ID: 15555461
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.
Kurella M; Chertow GM; Fried LF; Cummings SR; Harris T; Simonsick E; Satterfield S; Ayonayon H; Yaffe K
J Am Soc Nephrol; 2005 Jul; 16(7):2127-33. PubMed ID: 15888561
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
14. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
16. Measuring cognitive function with age: the influence of selection by health and survival.
Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM
Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086
[TBL] [Abstract][Full Text] [Related]
17. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
Hutchison LC; Jones SK; West DS; Wei JY
Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic differences in cognitive decline and the role of biomedical factors.
Koster A; Penninx BW; Bosma H; Kempen GI; Newman AB; Rubin SM; Satterfield S; Atkinson HH; Ayonayon HN; Rosano C; Yaffe K; Harris TB; Rooks RN; Van Eijk JT; Kritchevsky SB
Ann Epidemiol; 2005 Sep; 15(8):564-71. PubMed ID: 15922627
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and patterns of executive impairment in community dwelling Mexican Americans: results from the Hispanic EPESE Study.
Royall DR; Espino DV; Polk MJ; Palmer RF; Markides KS
Int J Geriatr Psychiatry; 2004 Oct; 19(10):926-34. PubMed ID: 15449370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
